Pruning the ricket thicket

The Journal of Clinical Investigation
Valentin David, Myles Wolf

Abstract

Overexpression of FGF23 results in hypophosphatemic rickets, which is characterized by renal phosphate wasting, inappropriately low circulating levels of the active form of vitamin D, and skeletal abnormalities. The precise mechanisms of how excess FGF23 leads to hypophosphatemic rickets are not clear. In this issue of the JCI, Bai and colleagues demonstrate that deletion or inhibition of CYP24A1, which initiates degradation of the active form of vitamin D, ameliorates skeletal abnormalities in two mouse models of hypophosphatemic rickets. While this work supports an important role for excess CYP24A1 activity in the pathogenesis of FGF23-mediated hypophosphatemic rickets, more work will need to be done before CYP24A1 inhibition can be integrated into the management of patients living with these diseases.

References

Mar 1, 1981·The Journal of Clinical Endocrinology and Metabolism·T CostaE E Delvin
Feb 7, 2001·The Journal of Clinical Endocrinology and Metabolism·D ZehnderM Hewison
Feb 18, 2004·The Journal of Clinical Investigation·Takashi ShimadaTakeyoshi Yamashita
Dec 14, 2004·Human Molecular Genetics·Anna Benet-PagèsBettina Lorenz-Depiereux
May 4, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Thomas O CarpenterKarl L Insogna
Jun 17, 2011·The New England Journal of Medicine·Karl P SchlingmannMartin Konrad
Feb 3, 2012·Physiological Reviews·Aline MartinL Darryl Quarles
Nov 7, 2012·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Simon WöhrleDiana Graus Porta
Feb 15, 2014·World Journal of Clinical Cases·Elena LionettiMario La Rosa
Feb 27, 2014·The Journal of Clinical Investigation·Thomas O CarpenterMunro Peacock
Jan 20, 2016·The Journal of Clinical Investigation·Xiuying BaiAndrew C Karaplis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Related Papers

Revista de pediatrie, obstetrică şi ginecologie. Pediatria
R PriŝcuA Orban
Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
M DomanasiewiczR Wasikowa
Ryōikibetsu shōkōgun shirīzu
K Kinuta, Y Seino
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
Simon WöhrleDiana Graus Porta
Current Therapy in Endocrinology and Metabolism
J D Hanna, J C Chan
© 2022 Meta ULC. All rights reserved